hematopoietic system
• mutant thymocytes show defective proliferation (>5-fold reduction) following receptor engagement in vitro
• induction of CD69 expression after TCR stimulation is reduced
|
• T cell development is altered as mutants have ~50% of thymocyte number of wild-type
|
• relative accumulation of CD25+CD44- thymocytes (double negative stage 3, DN3) compared to wild-type
• DN3/DN4 ratio is 10 in mutants vs ~2 in controls
|
• reduced numbers of T cells in lymph nodes and spleen
|
• mutants have ~50% of thymocyte number of wild-type
|
• numbers of mature thymocytes are 2-3-fold less than in controls
• however, DN thymocyte numbers are relatively normal
|
• numbers of mature thymocytes are 2-3-fold less than in controls
• however, DN thymocyte numbers are relatively normal
|
immune system
• mutant thymocytes show defective proliferation (>5-fold reduction) following receptor engagement in vitro
• induction of CD69 expression after TCR stimulation is reduced
|
• T cell development is altered as mutants have ~50% of thymocyte number of wild-type
|
• relative accumulation of CD25+CD44- thymocytes (double negative stage 3, DN3) compared to wild-type
• DN3/DN4 ratio is 10 in mutants vs ~2 in controls
|
• reduced numbers of T cells in lymph nodes and spleen
|
• mutants have ~50% of thymocyte number of wild-type
|
• numbers of mature thymocytes are 2-3-fold less than in controls
• however, DN thymocyte numbers are relatively normal
|
• numbers of mature thymocytes are 2-3-fold less than in controls
• however, DN thymocyte numbers are relatively normal
|
endocrine/exocrine glands
• mutants have ~50% of thymocyte number of wild-type
|
cellular
• mutant thymocytes show defective proliferation (>5-fold reduction) following receptor engagement in vitro
• induction of CD69 expression after TCR stimulation is reduced
|